| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
1 Division of Epidemiology and Clinical Research, Department of Pediatrics, 2 University of Minnesota Cancer Center and 3 Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota; and 4 Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota
Requests for reprints: Julie A. Ross, University of Minnesota Cancer Center, 420 Delaware Street Southeast, MMC 422, Minneapolis, MN 55455. Phone: 612-626-2902; Fax: 612-626-4842. E-mail: ross{at}epi.umn.edu
Overweight [body mass index (BMI) 25.0-29.9 kg/m2] and obesity (BMI
30 kg/m2) are risk factors for several malignancies. The Iowa Women's Health Study was examined to determine whether increased BMI was associated with leukemia development. Over 40,000 Iowa women (ages 55-69 years) completed a self-administered lifestyle and health questionnaire in 1986 that included current height and weight. Two hundred women developed leukemia during the period 1986 to 2001 including 74 acute myelogenous leukemia (AML) and 88 chronic lymphocytic leukemia. The risk of AML was increased among women who reported being overweight or obese (relative risk, 1.9; 95% confidence interval, 1.0-3.4; relative risk, 2.4; 95% confidence interval, 1.3-4.5; Ptrend = 0.006) compared with women of normal weight. There was little evidence of a positive association for chronic lymphocytic leukemia (Ptrend = 0.6). Given the prevalence of overweight and obesity in the United States, the population attributable risk of AML due to obesity could approach 30%.
This article has been cited by other articles:
![]() |
G. K Reeves, K. Pirie, V. Beral, J. Green, E. Spencer, D. Bull, and Million Women Study Collaboration Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study BMJ, December 1, 2007; 335(7630): 1134 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fernberg, A. Odenbro, R. Bellocco, P. Boffetta, Y. Pawitan, K. Zendehdel, and J. Adami Tobacco Use, Body Mass Index, and the Risk of Leukemia and Multiple Myeloma: A Nationwide Cohort Study in Sweden Cancer Res., June 15, 2007; 67(12): 5983 - 5986. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C-H. Chiu, S. M. Gapstur, P. Greenland, R. Wang, and A. Dyer Body Mass Index, Abnormal Glucose Metabolism, and Mortality from Hematopoietic Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2348 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M WARD, M. J THUN, L. M HANNAN, and A. JEMAL Interpreting cancer trends. Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 29 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Sinner, J. R. Cerhan, A. R. Folsom, and J. A. Ross Positive Association of Farm or Rural Residence with Acute Myeloid Leukemia Incidence in a Cohort of Older Women Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2446 - 2448. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MacInnis, D. R. English, J. L. Hopper, and G. G. Giles Body Size and Composition and the Risk of Lymphohematopoietic Malignancies J Natl Cancer Inst, August 3, 2005; 97(15): 1154 - 1157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |